We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

70 hedge funds and large institutions have $163M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

143% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 7

30% more funds holding

Funds holding: 54 → 70 (+16)

22% more capital invested

Capital invested by funds: $134M → $163M (+$29.6M)

Holders
70
Holders Change
+16
Holders Change %
+29.63%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
17
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
+$6.91M
2
MF
Magnetar Financial
Illinois
+$6.5M
3
OPU
Omni Partners US
California
+$6.16M
4
FTCM
First Trust Capital Management
Illinois
+$5.73M
5
FTCM
Fir Tree Capital Management
New York
+$4.44M

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$30.4M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$12.9M
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$4.66M
4
Goldman Sachs
Goldman Sachs
New York
-$3.27M
5
CAC
Cowen and Company
New York
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
26
Schonfeld Strategic Advisors
New York
$2.36M +$1.93M +196,946 +470%
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$2.33M -$1.12M -114,000 -33%
KC
28
Kepos Capital
New York
$2.23M +$946K +96,502 +75%
WA
29
Whitebox Advisors
Minnesota
$2.18M +$90.7K +9,249 +4%
CCA
30
Castle Creek Arbitrage
Colorado
$1.98M – – –
MI
31
MMCAP International
Cayman Islands
$1.98M – – –
AA
32
AQR Arbitrage
Connecticut
$1.86M +$339K +34,535 +23%
CL
33
CSS LLC
Illinois
$1.62M +$220K +22,426 +16%
WRBC
34
W.R. Berkley Corp
Connecticut
$1.55M -$231K -23,608 -13%
TCM
35
Tenor Capital Management
New York
$1.45M – – –
Nomura Holdings
36
Nomura Holdings
Japan
$1.3M – – –
AFM
37
Anson Funds Management
Texas
$1.24M – – –
YCM
38
Yakira Capital Management
Connecticut
$1.24M +$1.23M +125,000 New
VI
39
Vestcor Inc
New Brunswick, Canada
$1.11M – – –
Toronto Dominion Bank
40
Toronto Dominion Bank
Ontario, Canada
$1.03M – – –
RCM
41
Radcliffe Capital Management
Pennsylvania
$888K – – –
RA
42
Ramius Advisors
New York
$791K +$784K +80,000 New
Rockefeller Capital Management
43
Rockefeller Capital Management
New York
$733K +$629K +64,158 +642%
AIMCA
44
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$569K – – –
NAM
45
Nexpoint Asset Management
Texas
$544K – – –
CM
46
Crestline Management
Texas
$511K – – –
KKRC
47
Kohlberg Kravis Roberts & Co
New York
$508K +$90K +9,182 +22%
ACA
48
Arena Capital Advisors
California
$495K +$15.6K +1,587 +3%
DAM
49
Deltec Asset Management
New York
$494K – – –
CM
50
Cohanzick Management
New York
$414K +$392K +40,000 +2,105%
1
2
3 4

GRNA Hedge Fund Activity: Q3 2021 in Review

70 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q3 2021, worth a combined $163M — up 22% from $134M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new GRNA positions and 8 closed out — a net gain of 16 holders — while 17 added to existing stakes and 7 trimmed.

The largest buyer was Highbridge Capital Management, adding an estimated $6.91M. The largest seller was Hudson Bay Capital Management, cutting an estimated $30.4M.

  • 70 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q3 2021, up from 54 in Q2 2021.
  • Funds reported $163M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q3 2021, up 22% quarter-over-quarter.
  • 24 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q3 2021 and 8 closed out, a net change of +16 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q3 2021 was Highbridge Capital Management, an estimated $6.91M added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q3 2021 was Hudson Bay Capital Management, an estimated $30.4M sold.

Based on aggregated 13F filings for Q3 2021.